254 related articles for article (PubMed ID: 29959116)
1. [Regulation of γ-globin gene expression and its clinical applications].
Ju JY; Zhao Q
Yi Chuan; 2018 Jun; 40(6):429-444. PubMed ID: 29959116
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia.
Bao X; Zhang X; Wang L; Wang Z; Huang J; Zhang Q; Ye Y; Liu Y; Chen D; Zuo Y; Liu Q; Xu P; Huang B; Fang J; Lao J; Feng X; Li Y; Kurita R; Nakamura Y; Yu W; Ju C; Huang C; Mohandas N; Li D; Zhao C; Xu X
Am J Hum Genet; 2021 Apr; 108(4):709-721. PubMed ID: 33735615
[TBL] [Abstract][Full Text] [Related]
3. Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies.
Wienert B; Martyn GE; Funnell APW; Quinlan KGR; Crossley M
Trends Genet; 2018 Dec; 34(12):927-940. PubMed ID: 30287096
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.
Krivega I; Byrnes C; de Vasconcellos JF; Lee YT; Kaushal M; Dean A; Miller JL
Blood; 2015 Jul; 126(5):665-72. PubMed ID: 25979948
[TBL] [Abstract][Full Text] [Related]
5. Peptide nucleic acid (PNA) binding-mediated induction of human gamma-globin gene expression.
Wang G; Xu X; Pace B; Dean DA; Glazer PM; Chan P; Goodman SR; Shokolenko I
Nucleic Acids Res; 1999 Jul; 27(13):2806-13. PubMed ID: 10373600
[TBL] [Abstract][Full Text] [Related]
6. [Effect of genetic modifiers on the clinical severity of β-thalassemia].
Zhang QQ; Shang X; Lin WY; Xu XM
Yi Chuan; 2019 Aug; 41(8):669-676. PubMed ID: 31447418
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of fetal globin gene expression in adult erythroid cells.
Ginder GD
Transl Res; 2015 Jan; 165(1):115-25. PubMed ID: 24880147
[TBL] [Abstract][Full Text] [Related]
8. Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding.
Martyn GE; Wienert B; Yang L; Shah M; Norton LJ; Burdach J; Kurita R; Nakamura Y; Pearson RCM; Funnell APW; Quinlan KGR; Crossley M
Nat Genet; 2018 Apr; 50(4):498-503. PubMed ID: 29610478
[TBL] [Abstract][Full Text] [Related]
9. Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients.
Labie D; Pagnier J; Lapoumeroulie C; Rouabhi F; Dunda-Belkhodja O; Chardin P; Beldjord C; Wajcman H; Fabry ME; Nagel RL
Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2111-4. PubMed ID: 2580306
[TBL] [Abstract][Full Text] [Related]
10. CTD small phosphatase like 2 (CTDSPL2) can increase ε- and γ-globin gene expression in K562 cells and CD34+ cells derived from umbilical cord blood.
Ma YN; Zhang X; Yu HC; Zhang JW
BMC Cell Biol; 2010 Oct; 11():75. PubMed ID: 20932329
[TBL] [Abstract][Full Text] [Related]
11. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
[TBL] [Abstract][Full Text] [Related]
12. PUM1 mediates the posttranscriptional regulation of human fetal hemoglobin.
Elagooz R; Dhara AR; Gott RM; Adams SE; White RA; Ghosh A; Ganguly S; Man Y; Owusu-Ansah A; Mian OY; Gurkan UA; Komar AA; Ramamoorthy M; Gnanapragasam MN
Blood Adv; 2022 Dec; 6(23):6016-6022. PubMed ID: 35667093
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation patterns of β-globin cluster in β-thalassemia patients.
Bao X; Zuo Y; Chen D; Zhao C
Clin Epigenetics; 2020 Dec; 12(1):187. PubMed ID: 33272312
[TBL] [Abstract][Full Text] [Related]
15. The intrinsic genetic and epigenetic regulator factors as therapeutic targets, and the effect on fetal globin gene expression.
Adelvand P; Hamid M; Sardari S
Expert Rev Hematol; 2018 Jan; 11(1):71-81. PubMed ID: 29149573
[TBL] [Abstract][Full Text] [Related]
16. Genetic predisposition to β-thalassemia and sickle cell anemia in Turkey: a molecular diagnostic approach.
Basak AN; Tuzmen S
Methods Mol Biol; 2011; 700():291-307. PubMed ID: 21204041
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.
Ravi NS; Wienert B; Wyman SK; Bell HW; George A; Mahalingam G; Vu JT; Prasad K; Bandlamudi BP; Devaraju N; Rajendiran V; Syedbasha N; Pai AA; Nakamura Y; Kurita R; Narayanasamy M; Balasubramanian P; Thangavel S; Marepally S; Velayudhan SR; Srivastava A; DeWitt MA; Crossley M; Corn JE; Mohankumar KM
Elife; 2022 Feb; 11():. PubMed ID: 35147495
[TBL] [Abstract][Full Text] [Related]
18. The Novel Role of the B-Cell Lymphoma/Leukemia 11A (BCL11A) Gene in β-Thalassaemia Treatment.
Mahmoud Ahmed NH; Lai MI
Cardiovasc Hematol Disord Drug Targets; 2023; 22(4):226-236. PubMed ID: 36734897
[TBL] [Abstract][Full Text] [Related]
19. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
[TBL] [Abstract][Full Text] [Related]
20. Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.
Thein SL
Adv Exp Med Biol; 2017; 1013():27-57. PubMed ID: 29127676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
